Ogier LLP

Ogier have assisted first-of-its-kind music fund Hipgnosis Songs Fund Limited with its latest £75 million fundraising. The shares in Hipgnosis, which owns music from artists including...

Ogier Corporate Finance Limited (OCFL), the listing agent for Ogier, has advised Novelis Sheet Ingot GmbH, an indirect wholly-owned subsidiary of Novelis Inc (Novelis), in respect...

Ogier acted for Chinese issuer ShuiFa Group in US$200 million green bond offering. The company’s green bond framework outlines the group’s approach to developing a “green...

Olshan Frome Wolosky LLP successfully represented IsZo Capital in the case. IsZo Capital, a significant long-term shareholder of Nam Tai Property Inc., prevailed in its lawsuit against...

Ogier’s Cayman Islands team has assisted ARYA Sciences Acquisition Corp IV, the fourth healthcare-focused SPAC formed by Perceptive Advisors, on its $130 million initial public offering...

Ogier acted as Cayman Islands counsel on the Nasdaq initial public offerings (IPO) of special purpose acquisition companies (SPAC) Kismet Acquisition Two Corp and Kismet Acquisition...

Ogier, alongside lead counsel Cleary Gottlieb Steen & Hamilton LLP, advised ORI Capital on the launch of ORI Healthcare Fund II, its second healthcare-centered venture capital...

McCarthy Tétrault, Freshfields Bruckhaus Deringer and Ogier served as legal advisors to Li-Cycle, while Kirkland & Ellis and Stikeman Elliott served as legal advisors to Peridot...

Wilson Sonsini Goodrich & Rosati, P.C. advised Nautilus Biotechnology, while Kirkland & Ellis LLP, working alongside Ogier, advised Arya III on the deal. Latham & Watkins...

Davis Polk & Wardwell LLP and Ogier served as legal advisor to Clarivate, while Latham & Watkins LLP and Bedell Cristin served as legal advisor to...

Willis Towers Watson led the advice on the transactions, with Travers Smith LLP, Carey Olson (Guernsey) LLP, and Hengeler Mueller providing legal advice to the Trustees....

Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock...